Career Development Program

该职业发展计划（CDP）将用于培养新的莫菲特助理研究员（助理教授）或同等级别的莫菲特研究人员，特别是那些已经在皮肤恶性肿瘤研究领域工作的人员，或已经建立的莫菲特副研究员（副教授）或更高级别的莫菲特研究人员，他们是该领域的新成员，从事皮肤恶性肿瘤的转化研究。这也将有助于他们作为实验室调查员或临床试验人员向独立过渡。Moffitt Skin SPORE职业发展计划将提供指导、建议、指导、评估和财务资源，以继续支持每年最多两名教师级别的人员，每人2-3年。所有潜在的项目都有一个导师名单，该导师名单隶属于皮肤孢子或莫菲特综合黑色素瘤研究中心（CMRC）。目标是允许适当的和积极的个人发展一个独立的研究事业在转化科学专注于皮肤恶性肿瘤。它并不意味着作为研究生，博士后研究员，或临床研究员在血液肿瘤学，外科肿瘤学或皮肤病学的培训计划。与Moffitt Lung SPORE合作，每年可与Skin SPORE共同支持一个CDP奖，促进跨孢子受精。詹姆斯·穆尔博士将领导民主党。他在指导，研究和管理方面拥有丰富的经验，包括担任众多K08， K12， K99/R00和ACS奖学金的教师导师/导师，以及两个T32培训补助金的PI。申请将由穆尔博士主持的奖项评估委员会使用类似于NIH研究部门的科学标准进行审查。“重要性”、“创新”、“科学质量”的得分为1分（特别）~ 9分（差）。合作，出版和外部资助的潜力；与简短的理由和总体印象)，使用我们之前在CMRC中使用的审查表格。所有获资助的项目申请人须在前六个月结束时提交进度报告，并在资助的第一年结束时再次提交进度报告。进度报告将由奖项评估委员会审查，该委员会由Moffitt Skin SPORE IAC（成员名单见上文）和特别成员组成。已发表的手稿、已接受的摘要和潜在的转化影响将构成续期一年经费的最重要标准。

This Career Development Program (CDP) will be used to prepare new Moffitt investigators at the rank of Assistant Member (Assistant Professor) or equivalent, particularly those already in the field of cutaneous malignancy research, or established Moffitt investigators at the rank of Associate Member (Associate Professor) or higher who are new to the field for careers in translational research of cutaneous malignancies. It will also ease their transition to independence as investigators either in the laboratory or as clinical trialists. The Moffitt Skin SPORE career development program will provide guidance, advice, mentoring, evaluation, and financial resources for continuing support for up to two faculty-level persons per year for 2-3 years each. All prospective projects have a mentor listed that is affiliated with the Skin SPORE or the Comprehensive Melanoma Research Center (CMRC) at Moffitt. The goal is to allow appropriate and motivated individuals to develop an independent research career in translational science focused on cutaneous malignancies. It is not meant as a training program for graduate students, postdoctoral fellows, or clinical fellows in hematology-oncology, surgical oncology or dermatology. In collaboration with the Moffitt Lung SPORE, one CDP award per year may be co-supported by the Skin SPORE, promoting cross-SPORE fertilization. Dr. James Mule will lead the CDP. He has extensive experience in mentoring, research and administration, including serving as a faculty mentor/preceptor on numerous K08, K12, K99/R00 and ACS Fellowship awards, as well as the PI of two T32 training grants. Applications will be reviewed by an Award Evaluation Committee chaired by Dr. Mule using a scientific standard similar to a NIH study section. Scores of 1 (exceptional) to 9 (poor) will be assigned for categories of Significance, Innovation, Scientific quality. Collaboration, and Potential for publication and external funding; with brief justifications and overall impression), using a review form that we had employed previously for use in the CMRC. Progress reports will be required from all funded CDP project applicants at the end of the first six months, and again at the end of the first year of funding. The progress reports will be reviewed by the Award Evaluation Committee consisting of the Moffitt Skin SPORE IAC (see above for a list of members) and ad hoc members. Published manuscripts, abstracts accepted and the potential for translational impact will constitute the most important criteria for renewal of funding for an additional year.